These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1928270)

  • 1. Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections.
    Cokingtin CD; Hyndiuk RA
    Am J Ophthalmol; 1991 Oct; 112(4 Suppl):25S-28S. PubMed ID: 1928270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
    Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
    Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin-resistant Pseudomonas keratitis.
    Garg P; Sharma S; Rao GN
    Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis.
    Leibowitz HM
    Am J Ophthalmol; 1991 Oct; 112(4 Suppl):34S-47S. PubMed ID: 1928272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
    Sharma V; Sharma S; Garg P; Rao GN
    Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
    Onlen Y; Tamer C; Oksuz H; Duran N; Altug ME; Yakan S
    Microbiol Res; 2007; 162(1):62-8. PubMed ID: 16904302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
    Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.
    Kunimoto DY; Sharma S; Garg P; Rao GN
    Ophthalmology; 1999 Jan; 106(1):80-5. PubMed ID: 9917785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of the treatment of corneo-conjunctival infections with Didrosulfon].
    David M; Glăvan II; Midan F
    Otorinolaringologie; 1974; 19(2):173-6. PubMed ID: 4136429
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy for ocular bacterial infection.
    Baum J
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 1)():69-77. PubMed ID: 3459296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical fluoroquinolones for eye and ear.
    Morden NE; Berke EM
    Am Fam Physician; 2000 Oct; 62(8):1870-6. PubMed ID: 11057842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic therapy for ocular infection.
    Snyder RW; Glasser DB
    West J Med; 1994 Dec; 161(6):579-84. PubMed ID: 7856158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods.
    Valtonen V; Karppinen L; Kariniemi AL
    Scand J Infect Dis Suppl; 1989; 60():79-83. PubMed ID: 2547245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis.
    Tsai AC; Tseng MC; Chang SW; Hu FR
    J Formos Med Assoc; 1995 Dec; 94(12):760-4. PubMed ID: 8541741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas.
    Pachigolla G; Blomquist P; Cavanagh HD
    Eye Contact Lens; 2007 Jan; 33(1):45-9. PubMed ID: 17224678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis.
    Hobden JA; Reidy JJ; O'Callaghan RJ; Insler MS; Hill JM
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1940-4. PubMed ID: 2210988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.